Replimune (REPL) Other Non-Current Liabilities (2018 - 2026)
Replimune (REPL) reported Other Non-Current Liabilities of $455,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.6% from $941,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Dating back to fiscal Q4 2018, Replimune's Other Non-Current Liabilities record includes 19 quarters.
- Other Non-Current Liabilities has a three-year compound annual growth rate of -1.2% (FY2023 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $941,000 in FY2025 (+19.7%), $786,000 in FY2024 (+66.5%) and $472,000 in FY2023.
- Five-year quarterly Other Non-Current Liabilities spans a low of $455,000 in fiscal Q4 2026 and a high of $1.27 million in fiscal Q3 2025.
- Year over year, Other Non-Current Liabilities has now declined in each of the last three quarters, with growth averaging 4.6% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q2 2025 (growth of 66.5%); the low point was fiscal Q4 2026 (a decline of 51.6%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $455,000 (Q4 2026), $693,000 (Q3 2026) and $941,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 455,000.00 |
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 693,000.00 |
| Sep 30, 2025 | 941,000.00 |
| Jun 30, 2025 | 941,000.00 |
| Mar 31, 2025 | 941,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 786,000.00 |
| Mar 31, 2024 | 786,000.00 |
| Dec 31, 2023 | 793,000.00 |
| Sep 30, 2023 | 472,000.00 |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | 168,000.00 |
| Sep 30, 2018 | 36,000.00 |
| Jun 30, 2018 | 7.09 Mn |
| Mar 31, 2018 | 1.64 Mn |
API Access
Replimune Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();